CUC Inc.
Stock Price Chart
2026/07/10 UpdatedPrice Trend
2026/07/10 UpdatedPrice & Trading Details
2026/07/10 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/07/01Earnings Calendar
Updated 2026/07/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/04/29 | ¥46.30 | ¥48.48 | +4.7% |
| 2026/02/02 | ¥29.00 | ¥27.98 | -3.5% |
| 2025/11/10 | ¥29.74 | ¥13.79 | -53.6% |
| 2025/08/04 | ¥24.64 | ¥7.10 | -71.2% |
Shareholder Composition
Updated 2026/07/01Financial Performance
2026/07/05 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥35,210M | ¥33,025M | ¥47,043M | ¥54,353M |
| Gross Profit | ¥13,776M | ¥15,923M | ¥23,172M | ¥25,413M |
| Operating Income | ¥3,683M | ¥3,736M | ¥5,343M | ¥5,782M |
| Pretax Income | ¥3,733M | ¥4,423M | ¥5,757M | ¥5,845M |
| Net Income | ¥2,423M | ¥2,595M | ¥3,131M | ¥2,854M |
| EPS | ¥113.91 | ¥93.99 | ¥106.81 | - |
| Operating Margin | 10.46% | 11.31% | 11.36% | 10.64% |
| Balance Sheet | ||||
| Total Assets | ¥39,750M | ¥62,836M | ¥85,167M | ¥98,054M |
| Total Equity | ¥11,704M | ¥27,316M | ¥29,678M | ¥33,253M |
| Total Liabilities | ¥28,046M | ¥35,520M | ¥55,489M | ¥64,801M |
| Cash | ¥4,120M | ¥8,256M | ¥7,533M | ¥15,835M |
| Interest-bearing Debt | ¥21,452M | ¥26,719M | ¥43,544M | ¥52,533M |
| Equity Ratio | 29.44% | 43.47% | 34.85% | 33.91% |
| D/E Ratio | 1.83 | 0.98 | 1.47 | 1.58 |
| Cash Flow | ||||
| Operating CF | ¥2,357M | ¥4,156M | ¥2,503M | ¥5,706M |
| Investing CF | -¥6,682M | -¥14,746M | ¥4,450M | -¥3,420M |
| Financing CF | ¥3,972M | ¥14,373M | -¥7,599M | ¥5,957M |
| Free CF | -¥3,226M | -¥747M | -¥3,084M | -¥1,034M |
| Efficiency | ||||
| ROE | 20.70% | 9.50% | 10.55% | 8.58% |
| ROA | 6.10% | 4.13% | 3.68% | 2.91% |
Latest IR Information
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥1,000
Rating Score: - (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
CUC Inc. offers healthcare services in Japan and internationally. It provides medical institution operations support, including strategic, administrative, marketing, HR/recruiting, and procurement support, as well as support for IT, accounting, general affairs, etc.; medical institution revenue growth assistance services, such as M and A, post-merger integration, hospital bed conversion, and clinic launches; and medical institution cost optimization support. The company also provides meals to hospitals, welfare facilities, and hospice facilities; and leases and maintains real estate for medical institutions. In addition, it operates a hospice specializing in care for people in the terminal stages of cancer or with intractable diseases, as well as a home nursing and care business under the ReHOPE brand name. Further, the company offers home nursing; day service; in-home nursing care support; and in-home clinical trials and in-home monitoring services. The company provides its support service to in-home, hospital, dialysis, and outpatient care. The company was incorporated in 2014 and is based in Minato, Japan. CUC Inc. is a subsidiary of M3 Inc.
